
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Optimizing antithrombotic therapy following mitral valve repair: a comprehensive network meta-analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251F5E8AEF58A3051F5E00106235DA.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmccard">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374401/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Cardiovascular Disorders">
<meta name="citation_title" content="Optimizing antithrombotic therapy following mitral valve repair: a comprehensive network meta-analysis">
<meta name="citation_author" content="Mohamed Ibrahim Gbreel">
<meta name="citation_author_institution" content="Faculty of Medicine and Surgery, October 6 University, Giza, Egypt">
<meta name="citation_author_institution" content="Department of Cardiology, Epyptian Railway Medical Centre (ERMC), Cairo, Egypt">
<meta name="citation_author" content="Mohamed Hamouda Elkasaby">
<meta name="citation_author_institution" content="Faculty of Medicine and Surgery, Al-Azhar University, Cairo, Egypt">
<meta name="citation_author" content="Marwa Hassan">
<meta name="citation_author_institution" content="Department of Immunology, Theodor Bilharz Research Institute, Giza, Egypt">
<meta name="citation_author" content="Marc Ulrich Becher">
<meta name="citation_author_institution" content="Department of Cardiology, Städtisches Klinikum Solingen, Solingen, Germany">
<meta name="citation_author" content="Mahmoud Balata">
<meta name="citation_author_institution" content="Department of cardiology, University hospital Rostock, Rostock, Germany">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="628">
<meta name="citation_doi" content="10.1186/s12872-025-04974-4">
<meta name="citation_pmid" content="40849614">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374401/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374401/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374401/pdf/12872_2025_Article_4974.pdf">
<meta name="description" content="Mitral regurgitation (MR) presents either as primary or secondary, with options for surgical or transcatheter repair. Thromboembolic risks following surgery are significant despite the use of antithrombotic medications, and guidelines for ...">
<meta name="og:title" content="Optimizing antithrombotic therapy following mitral valve repair: a comprehensive network meta-analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Mitral regurgitation (MR) presents either as primary or secondary, with options for surgical or transcatheter repair. Thromboembolic risks following surgery are significant despite the use of antithrombotic medications, and guidelines for ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374401/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374401">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12872-025-04974-4"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12872_2025_Article_4974.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374401%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374401/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374401/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374401/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmccard.png" alt="BMC Cardiovascular Disorders logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Cardiovascular Disorders" title="Link to BMC Cardiovascular Disorders" shape="default" href="https://bmccardiovascdisord.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Cardiovasc Disord</button></div>. 2025 Aug 23;25:628. doi: <a href="https://doi.org/10.1186/s12872-025-04974-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12872-025-04974-4</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Cardiovasc%20Disord%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Cardiovasc%20Disord%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Cardiovasc%20Disord%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Cardiovasc%20Disord%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Optimizing antithrombotic therapy following mitral valve repair: a comprehensive network meta-analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gbreel%20MI%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Mohamed Ibrahim Gbreel</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Mohamed Ibrahim Gbreel</span></h3>
<div class="p">
<sup>1</sup>Faculty of Medicine and Surgery, October 6 University, Giza, Egypt </div>
<div class="p">
<sup>2</sup>Department of Cardiology, Epyptian Railway Medical Centre (ERMC), Cairo, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gbreel%20MI%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohamed Ibrahim Gbreel</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Elkasaby%20MH%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mohamed Hamouda Elkasaby</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mohamed Hamouda Elkasaby</span></h3>
<div class="p">
<sup>3</sup>Faculty of Medicine and Surgery, Al-Azhar University, Cairo, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Elkasaby%20MH%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohamed Hamouda Elkasaby</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hassan%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Marwa Hassan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Marwa Hassan</span></h3>
<div class="p">
<sup>4</sup>Department of Immunology, Theodor Bilharz Research Institute, Giza, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hassan%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marwa Hassan</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Becher%20MU%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Marc Ulrich Becher</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Marc Ulrich Becher</span></h3>
<div class="p">
<sup>5</sup>Department of Cardiology, Städtisches Klinikum Solingen, Solingen, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Becher%20MU%22%5BAuthor%5D" class="usa-link"><span class="name western">Marc Ulrich Becher</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balata%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mahmoud Balata</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Mahmoud Balata</span></h3>
<div class="p">
<sup>6</sup>Department of cardiology, University hospital Rostock, Rostock, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balata%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mahmoud Balata</span></a>
</div>
</div>
<sup>6,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Faculty of Medicine and Surgery, October 6 University, Giza, Egypt </div>
<div id="Aff2">
<sup>2</sup>Department of Cardiology, Epyptian Railway Medical Centre (ERMC), Cairo, Egypt </div>
<div id="Aff3">
<sup>3</sup>Faculty of Medicine and Surgery, Al-Azhar University, Cairo, Egypt </div>
<div id="Aff4">
<sup>4</sup>Department of Immunology, Theodor Bilharz Research Institute, Giza, Egypt </div>
<div id="Aff5">
<sup>5</sup>Department of Cardiology, Städtisches Klinikum Solingen, Solingen, Germany </div>
<div id="Aff6">
<sup>6</sup>Department of cardiology, University hospital Rostock, Rostock, Germany </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 2; Accepted 2025 Jun 23; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374401  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40849614/" class="usa-link">40849614</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Mitral regurgitation (MR) presents either as primary or secondary, with options for surgical or transcatheter repair. Thromboembolic risks following surgery are significant despite the use of antithrombotic medications, and guidelines for postoperative anticoagulation therapy lack consistency. This systematic review aims to compare antithrombotic medications after mitral valve repair (MVR). In this study, we intend to compare antithrombotic medications after MVR.</p></section><section id="sec2"><h3 class="pmc_sec_title">Materials and methods</h3>
<p id="Par2">The study followed the Cochrane handbook and PRISMA guidelines. We systematically searched databases (PubMed, Scopus, Ovid, Cochrane, Web of Science) until June 2024 for TMVR studies using specific criteria. Quality assessment utilized the Newcastle-Ottawa scale. Data extraction encompassed study characteristics and outcomes. Primary outcomes included thromboembolic events and bleeding within six months. Statistical analysis employed R software to assess heterogeneity and publication bias.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">From the 121 articles screened, 12 were included in the study. These cohort studies, involving 20,644 participants, spanned from 2008 to 2022. While most studies were of good to high quality, some exhibited lower quality. Analysis favored oral anticoagulants (OAC) over single antiplatelet therapy (SAPT) for reducing bleeding risk (RR = 0.31, 95% CI: [0.11–0.87], <em>P</em> &lt; 0.05), with moderate heterogeneity. Thromboembolic events did not significantly differ among interventions. Transient ischemic attacks and stroke outcomes were similar between SAPT and vitamin K antagonists (VKA). Six-month mortality rates were comparable between SAPT and VKA, with notable heterogeneity and higher mortality with SAPT in one study. Qualitative synthesis highlighted procedural success rates and bleeding complications across different interventions in transcatheter mitral valve repair studies.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">OACs showed a lower risk of bleeding compared to antiplatelet therapies, while VKAs and OAC + SAPT may reduce thromboembolic events. No significant differences were found in stroke, TIA, or short-term mortality. These findings support individualized therapy and highlight the need for further randomized trials.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12872-025-04974-4.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> ASA, Clopidogrel, Anticoagulant, Mitral valve repair, Mitral regurgitation, Network meta-analysis</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par34">Mitral regurgitation (MR) is one of the most prevalent valvular heart diseases, affecting more than twenty-four million people worldwide, and is associated with high mortality and morbidity rates [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Pathological changes in the mitral valve cause primary MR. In the Western world, degenerative changes are the most common cause, while in low-income countries, rheumatic heart disease is the leading cause. [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. On the other hand, secondary MR is the result of abnormal changes in the left ventricle, where the MV is normal. It can also be caused by atrial fibrillation (AF) or left atrial enlargement [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>].</p>
<p id="Par35">Current international guidelines offer varying recommendations regarding the choice and duration of antithrombotic therapy post-MVR. The 2020 ACC/AHA guidelines suggest oral anticoagulation for at least 3 months after mitral valve repair (MVR) in patients without other indications for long-term anticoagulation, with a preference for warfarin (Class IIa recommendation) by Otto CM et al., 2021. Conversely, the 2017 ESC/EACTS guidelines are less specific, recommending individualized decision-making based on patient risk profiles and procedural factors, without a strong preference for anticoagulation versus antiplatelet therapy. These discrepancies highlight the ongoing uncertainty surrounding optimal postoperative antithrombotic strategies.”</p>
<p id="Par36">The conjoint guidelines of the European Heart Association and the European Association for Cardio-Thoracic Surgery (ESC-EACTS) [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>] and the American Guidelines of the American College of Cardiology and the American Heart Association (ACC-AHA) [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>] recommend surgical mitral valve repair (SMVR) as the gold standard treatment for symptomatic MR for operable patients, while the transcatheter MV repair (PMVR) is typically recommended for those who deemed inoperable or high surgical risk. Thromboembolic (TE) events following SMVR vary from 0.4 to 1.6% per year and increase to 2.5% during the first month after the surgery, even with routine antithrombotic (AT) medications [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par37">After MVR, consistent guidelines on anticoagulation therapy are lacking, leading to varying clinical practices. Interestingly, In A large cohort of patients in North America who underwent MVR between 2008 and 2010, a real-world practice patterns, as described by Suri et al. [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>], demonstrate that anticoagulation decisions are often driven by institutional or physician preferences rather than patient-specific characteristics, further emphasizing the need for more robust comparative evidence [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p>
<p id="Par38">The recommendations provided by international guidelines for postoperative antithrombotic management have been controversial as well [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. In this systematic review and network meta-analysis, we aim to compare different AT medications after MVR in a network meta-analysis.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<p id="Par39">We followed the approaches for conducting the current study based on the Cochrane handbook of systematic reviews on interventions [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. During the drafting of our manuscript, we strictly followed the recommended reporting items for the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<section id="Sec3"><h3 class="pmc_sec_title">Search strategy</h3>
<p id="Par40">The following electronic databases were systematically searched: PubMed, Web of Science (WOS), Scopus, Ovid, and Cochrane till 27 June 2024. We used the following search strategy for searching on prespecified databases: (Acetylsalicylic OR Acylpyrin OR Aloxiprimum OR Colfarit OR Dispril OR Easprin OR Ecotrin OR Endosprin OR Magnecyl OR Micristin OR Polopirin OR Polopiryna OR Solprin OR Solupsan OR Zorprin OR Acetysal OR lysine OR aspirin OR aspiryl-polylysine OR Solusprin OR Aspisol OR Flectadol OR Solusprin OR Venopirin OR Aspegic OR Clopidogrel OR Iscover OR PCR OR PlaviX OR <em>Clogrel</em> OR SC 25989 C OR SR 25989) AND (Apo-Warfarin OR Aldocumar OR Gen-Warfarin OR Warfant OR Coumadin OR Marevan OR Warfarin OR Coumadine OR Tedicumar OR Pradaxa OR Dabigatran OR rivaroxaban OR Xarelto OR Eliquis OR apixaban OR edoxaban OR Savaysa OR Lixiana OR Roteas OR <em>Betrixaban</em> OR Bevyxxa) AND (Mitral OR Bicuspid OR TMVR OR Repair). All the included studies’ references were screened to avoid missing any studies and guarantee high-quality screening.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Eligibility criteria</h3>
<p id="Par41">We included studies that enrolled adult patients who underwent MVR either through a surgical approach (SMVR) or transcatheter techniques (TMVR). The primary focus was on TMVR. The data from surgical cohorts were considered mainly in secondary and comparative analyses when relevant. Eligible studies had to evaluate antithrombotic interventions, specifically acetylsalicylic acid (ASA), clopidogrel, vitamin K antagonists (VKA), or other oral anticoagulants (OACs), alone or in combination. We included both randomized controlled trials (RCTs) and prospective or retrospective cohort studies that reported at least one of the predefined outcomes of interest. We excluded studies based on the following criteria: non-human studies, case reports, case series, conference abstracts, editorials, reviews, studies lacking original patient data, and non-English publications. Duplicate publications and studies with overlapping data were assessed carefully.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Screening and study selection</h3>
<p id="Par42">Using EndNote software [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]We gathered various records from multiple databases and eliminated duplicates. The retrieved references underwent screening to assess their relevance. This process was conducted in two steps: first, title and abstract screening, followed by full-text screening for final eligibility. The interventions included in the final analysis after screening were dual antiplatelet therapy (DAPT), Warfarin (VKA), Aspirin/single antiplatelet therapy (SAPT), oral anticoagulant (OAC), and no antiplatelet therapy (No APT). At least two independent authors performed each step, and their findings were compared; group discussions resolved any disagreements.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Quality assessment</h3>
<p id="Par43">An adapted version of the Newcastle-Ottawa scale (NOS) quality assessment [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>] for cohort studies was used for quality assessment of each included study. The scale encompasses the following domains: Sample selection criteria, Comparability and Exposure. It adopts a star-awarding system for specific methodological sections, which permits calculating an overall quality score for each study. The scale gives a maximum score of 10 points, where the studies were categorized according to their score as follows: high risk of bias (0–3 points), moderate risk of bias (4–6 points), or low risk of bias (≥ 7 points). Any disagreements during the quality assessment were resolved through mutual consensus and/or by consulting the third senior author.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Data extraction</h3>
<p id="Par44">Two independent authors extracted the following data from the included studies. Extracting summary of included studies included the design, setting, sample size, follow-up duration, population definition, outcomes, and baseline characteristics of the patients in the included studies.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Endpoints</h3>
<p id="Par45">The primary outcomes of our study included thromboembolic events, bleeding events, transient ischemic attacks (TIAs), stroke, and mortality events within six months.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par46">We used R version 4.2.2 (2022-10-31) [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>], and R Studio version 2022.07.2 (2009–2022) RStudio, Inc.) [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Dichotomous data were analyzed as risk ratio (RR) and 95% confidence interval (CI) and continuous data as mean difference (MD) and 95% CI. Statistical heterogeneity among the studies was assessed by visual inspection of the forest plot, besides using I-squared (I<sup>2</sup>) and chi-squared (Chi<sup>2</sup>) statistics. I<sup>2</sup> values of 50% were indicative of high heterogeneity. A random-effects model was applied when there was a significant variation in the data. Other than that, the fixed-effect model was applied. Egger test was used to assess the publication bias [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p></section></section><section id="Sec10"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec11"><h3 class="pmc_sec_title">Literature search</h3>
<p id="Par47">The computerized search and reference lists of the databases yielded 6520 articles. After duplicates were removed, 6060 articles were screened. Following the primary screening, 121 articles were included. The full texts of these papers were processed to secondary screening, with 12 articles [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>–<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>] included in the study and nine [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>] included in the analysis. (Fig. <a href="#Fig1" class="usa-link">1</a>: PRISMA flow diagram.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/1b0ed72ec29c/12872_2025_4974_Fig1_HTML.jpg" loading="lazy" id="MO1" height="884" width="744" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PRISMA Flow Diagram, showing the systematic review process, including initial identification, screening, eligibility assessment, and final study inclusion</p></figcaption></figure></section><section id="Sec12"><h3 class="pmc_sec_title">Characteristics of the included studies</h3>
<p id="Par49">A total of 20,644 were included in the study and 19,294 were included in the screening. All these studies were cohort studies either prospective or retrospective done between 2008 and 2022. The follow-up durations ranged between 45 days to 10 years. For in-depth insight into the participants, Table <a href="#Tab1" class="usa-link">1</a> and <a href="#Tab2" class="usa-link">2</a> presents detailed characteristics.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Summary of the included studies</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Study ID</th>
<th align="left" colspan="1" rowspan="1">Year</th>
<th align="left" colspan="1" rowspan="1">Setting</th>
<th align="left" colspan="1" rowspan="1">Design</th>
<th align="left" colspan="1" rowspan="1">Sample Size</th>
<th align="left" colspan="1" rowspan="1">Follow-up duration</th>
<th align="left" colspan="1" rowspan="1">Type of repair</th>
<th align="left" colspan="1" rowspan="1">Population definition</th>
<th align="left" colspan="1" rowspan="1">Primary outcome measures</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">(Benito-González, et al.) [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]</td>
<td align="left" colspan="1" rowspan="1">2018</td>
<td align="left" colspan="1" rowspan="1">Spain</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">80</td>
<td align="left" colspan="1" rowspan="1">523.5 days</td>
<td align="left" colspan="1" rowspan="1">Percutaneous</td>
<td align="left" colspan="1" rowspan="1">Patients underwent PMVR.</td>
<td align="left" colspan="1" rowspan="1">Admission for HF and all-cause mortality.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">(Körber, et al.) et al. [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]</td>
<td align="left" colspan="1" rowspan="1">2018</td>
<td align="left" colspan="1" rowspan="1">Germany</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">347</td>
<td align="left" colspan="1" rowspan="1">1 Year</td>
<td align="left" colspan="1" rowspan="1">Percutaneous</td>
<td align="left" colspan="1" rowspan="1">Patients who underwent PMVR.</td>
<td align="left" colspan="1" rowspan="1">Occurrence of bleeding.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hohmann et al. [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]</td>
<td align="left" colspan="1" rowspan="1">2022</td>
<td align="left" colspan="1" rowspan="1">Germany</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">1342</td>
<td align="left" colspan="1" rowspan="1">6 months</td>
<td align="left" colspan="1" rowspan="1">Percutaneous</td>
<td align="left" colspan="1" rowspan="1">
<p>Patients (≥ 18 years of age) who received MitraClip</p>
<p>for the first time.</p>
</td>
<td align="left" colspan="1" rowspan="1">(1) MACE defined as a combined endpoint of cardiovascular mortality, MI, and ischemic stroke, and (2) All-cause mortality (3) intracranial bleeding, (4) major extracranial bleeding and GIT bleeding.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Meurin et al. [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]</td>
<td align="left" colspan="1" rowspan="1">2008</td>
<td align="left" colspan="1" rowspan="1">Multi-centric</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">350</td>
<td align="left" colspan="1" rowspan="1">45 days</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Patients underwent MVR</td>
<td align="left" colspan="1" rowspan="1">Occurrence of thromboembolic events within 6 weeks of the procedure.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Paparella et al. [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]</td>
<td align="left" colspan="1" rowspan="1">2016</td>
<td align="left" colspan="1" rowspan="1">Multi-centric</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">1882</td>
<td align="left" colspan="1" rowspan="1">6 months</td>
<td align="left" colspan="1" rowspan="1">Percutaneous</td>
<td align="left" colspan="1" rowspan="1">Patients aged more than or equal to 18 years at time of surgery underwent isolated MVR with mitral ring implantation to treat MR, and in sinus rhythm at hospital discharge.</td>
<td align="left" colspan="1" rowspan="1">Primary efficacy outcome was the incidence of arterial thromboembolic events within 6 months and primary safety outcome was the incidence of major bleeding within 6 months.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Seeger et al. [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]</td>
<td align="left" colspan="1" rowspan="1">2019</td>
<td align="left" colspan="1" rowspan="1">Germany</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">254</td>
<td align="left" colspan="1" rowspan="1">10 years</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Patients underwent TMVR.</td>
<td align="left" colspan="1" rowspan="1">All-cause mortality, all stroke, and rehospitalization for congestive heart failure or myocardial infarction.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Suri et al. [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]</td>
<td align="left" colspan="1" rowspan="1">2013</td>
<td align="left" colspan="1" rowspan="1">North America</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">13,082</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Patients who underwent primary mitral valve repair. Those patients having other major concomitant operations or with an indication/contraindication to warfarin were excluded.</td>
<td align="left" colspan="1" rowspan="1">Complications (AF, Permanent stroke, Reoperation for bleeding/tamponade), length of hospital stay, use of blood products, medications at discharge (Aspirin, or Beta-blockers)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Waechter et al. [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]</td>
<td align="left" colspan="1" rowspan="1">2022</td>
<td align="left" colspan="1" rowspan="1">Germany</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">609</td>
<td align="left" colspan="1" rowspan="1">419 days</td>
<td align="left" colspan="1" rowspan="1">TEER</td>
<td align="left" colspan="1" rowspan="1">Patients undergoing TEER with the MitraClip.</td>
<td align="left" colspan="1" rowspan="1">
<p>All-cause in-hospital death and all-cause</p>
<p>mortality during follow-up.</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Van der Wall et al. [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]</td>
<td align="left" colspan="1" rowspan="1">2018</td>
<td align="left" colspan="1" rowspan="1">Netherlands</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">469</td>
<td align="left" colspan="1" rowspan="1">3 months</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Patients with mitral valve repair</td>
<td align="left" colspan="1" rowspan="1">The combined incidence of thromboembolic and bleeding complications.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Noohi et al. [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]</td>
<td align="left" colspan="1" rowspan="1">2020</td>
<td align="left" colspan="1" rowspan="1">Iran</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">297</td>
<td align="left" colspan="1" rowspan="1">1 year</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Patients undergoing mitral valve repair.</td>
<td align="left" colspan="1" rowspan="1">Safety and efficacy of rivaroxaban.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Valeur et al. [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]</td>
<td align="left" colspan="1" rowspan="1">2016</td>
<td align="left" colspan="1" rowspan="1">Denmark</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">2188</td>
<td align="left" colspan="1" rowspan="1">4.9 years</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Patients who underwent mitral valve repair.</td>
<td align="left" colspan="1" rowspan="1">Mortality and stroke</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Watt et al. [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]</td>
<td align="left" colspan="1" rowspan="1">2020</td>
<td align="left" colspan="1" rowspan="1">USA</td>
<td align="left" colspan="1" rowspan="1">Cohort</td>
<td align="left" colspan="1" rowspan="1">1097</td>
<td align="left" colspan="1" rowspan="1">10 years</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Patients who underwent elective mitral valve repair.</td>
<td align="left" colspan="1" rowspan="1">Occurrence of thromboembolic events.</td>
</tr>
<tr><td align="left" colspan="9" rowspan="1">
<em>HF</em>, Heart failure, <em>PMVR</em>, percutaneous edge-to-edge mitral valve repair, <em>MACE</em>, Major adverse cardiovascular events, <em>MI</em>, myocardial infarction, <em>MVR</em>, mitral valve repair, <em>MR</em>, mitral regurgitation, <em>TMVR</em>, transcatheter mitral valve repair, <em>AF</em>, Atrial fibrillation, <em>TEER</em>, Transcatheter Edge-to-Edge Repair</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Baseline characteristics of the included studies</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Study ID</th>
<th align="left" rowspan="2" colspan="1">Arms</th>
<th align="left" rowspan="2" colspan="1">Sample</th>
<th align="left" rowspan="2" colspan="1">Age, y mean (SD)</th>
<th align="left" rowspan="2" colspan="1">Gender, Male, <em>n</em> (%)</th>
<th align="left" rowspan="2" colspan="1">BMI, kg/m2 mean(SD)</th>
<th align="left" colspan="4" rowspan="1">Comorbidities <em>n</em>(%)</th>
<th align="left" colspan="4" rowspan="1">Echocardiographic measures</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">AF</th>
<th align="left" colspan="1" rowspan="1">DM</th>
<th align="left" colspan="1" rowspan="1">HTN</th>
<th align="left" colspan="1" rowspan="1">Stroke</th>
<th align="left" colspan="1" rowspan="1">Functional MR etiology, <em>n</em> (%)</th>
<th align="left" colspan="1" rowspan="1">LVEF, % mean(SD)</th>
<th align="left" colspan="1" rowspan="1">Transmitral mean gradient, mm Hg mean(SD)</th>
<th align="left" colspan="1" rowspan="1">Pulmonary artery systolic pressure, mm Hg mean(SD)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"> Benito-González et al. 2018 [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]</td>
<td align="left" colspan="1" rowspan="1">SAPT, DAPT, VKA, and Dual OAC</td>
<td align="left" colspan="1" rowspan="1">80</td>
<td align="left" colspan="1" rowspan="1">74.6 (10.1)</td>
<td align="left" colspan="1" rowspan="1">52 (65)</td>
<td align="left" colspan="1" rowspan="1">26.7 (5.1)</td>
<td align="left" colspan="1" rowspan="1">47 (58.8)</td>
<td align="left" colspan="1" rowspan="1">23 (28.8)</td>
<td align="left" colspan="1" rowspan="1">52 (65)</td>
<td align="left" colspan="1" rowspan="1">3 (3.6)</td>
<td align="left" colspan="1" rowspan="1">60 (75)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">46.9 (16.2)</td>
</tr>
<tr>
<td align="left" rowspan="5" colspan="1"> Hohmann et al. 2022 [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]</td>
<td align="left" colspan="1" rowspan="1">DAPT</td>
<td align="left" colspan="1" rowspan="1">157</td>
<td align="left" colspan="1" rowspan="1">74.6 (10.4</td>
<td align="left" colspan="1" rowspan="1">103 (65.6)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">35 (22.3)</td>
<td align="left" colspan="1" rowspan="1">74 (47.1)</td>
<td align="left" colspan="1" rowspan="1">134 (85.4)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mono OAC</td>
<td align="left" colspan="1" rowspan="1">261</td>
<td align="left" colspan="1" rowspan="1">77.8 (7.4)</td>
<td align="left" colspan="1" rowspan="1">152 (58.2)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">206 (78.9)</td>
<td align="left" colspan="1" rowspan="1">117 (44.8)</td>
<td align="left" colspan="1" rowspan="1">243 (93.1)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Duo OAC</td>
<td align="left" colspan="1" rowspan="1">279</td>
<td align="left" colspan="1" rowspan="1">77.0 (8.2)</td>
<td align="left" colspan="1" rowspan="1">168 (60.2)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">207 (74.2)</td>
<td align="left" colspan="1" rowspan="1">128 (45.9)</td>
<td align="left" colspan="1" rowspan="1">253 (90.7)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Triple OAC</td>
<td align="left" colspan="1" rowspan="1">37</td>
<td align="left" colspan="1" rowspan="1">77.9 (6.8)</td>
<td align="left" colspan="1" rowspan="1">25 (67.6)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">23 (62.2)</td>
<td align="left" colspan="1" rowspan="1">16 (43.2)</td>
<td align="left" colspan="1" rowspan="1">33 (89.2)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">No APT</td>
<td align="left" colspan="1" rowspan="1">282</td>
<td align="left" colspan="1" rowspan="1">75.9 (9.7)</td>
<td align="left" colspan="1" rowspan="1">179 (63.5)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">202 (71.6)</td>
<td align="left" colspan="1" rowspan="1">116 (41.1)</td>
<td align="left" colspan="1" rowspan="1">256 (90.8)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Körber et al. 2018 [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]</td>
<td align="left" colspan="1" rowspan="1">VKA, OAC, SAPT, and DAPT</td>
<td align="left" colspan="1" rowspan="1">347</td>
<td align="left" colspan="1" rowspan="1">76 (13.7)</td>
<td align="left" colspan="1" rowspan="1">203 (58.5)</td>
<td align="left" colspan="1" rowspan="1">25.3 (4.7)</td>
<td align="left" colspan="1" rowspan="1">194 (55.9%)</td>
<td align="left" colspan="1" rowspan="1">89 (25.6%)</td>
<td align="left" colspan="1" rowspan="1">238 (68.6%)</td>
<td align="left" colspan="1" rowspan="1">44 (12.7%)</td>
<td align="left" colspan="1" rowspan="1">183 (52.7%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Meurin et al. 2008 [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]</td>
<td align="left" colspan="1" rowspan="1">VKA</td>
<td align="left" colspan="1" rowspan="1">230</td>
<td align="left" colspan="1" rowspan="1">59 (14)</td>
<td align="left" colspan="1" rowspan="1">
<p>150</p>
<p>(65%)</p>
</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">53 (23)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">56 (11)</td>
<td align="left" colspan="1" rowspan="1">2.8 (1.7)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">No APT</td>
<td align="left" colspan="1" rowspan="1">35</td>
<td align="left" colspan="1" rowspan="1">60 (15)</td>
<td align="left" colspan="1" rowspan="1">25 (71%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">57 (10)</td>
<td align="left" colspan="1" rowspan="1">3.2 (2.1)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Paparella et al. 2016 [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]</td>
<td align="left" colspan="1" rowspan="1">SAPT</td>
<td align="left" colspan="1" rowspan="1">286</td>
<td align="left" colspan="1" rowspan="1">56.3 (17.3)</td>
<td align="left" colspan="1" rowspan="1">180 (62.9)</td>
<td align="left" colspan="1" rowspan="1">25.4 (4.0)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">16 (5.6)</td>
<td align="left" colspan="1" rowspan="1">145 (50.7)</td>
<td align="left" colspan="1" rowspan="1">5 (1.7)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VKA</td>
<td align="left" colspan="1" rowspan="1">858</td>
<td align="left" colspan="1" rowspan="1">57.7 (12.9)</td>
<td align="left" colspan="1" rowspan="1">539 (62.8)</td>
<td align="left" colspan="1" rowspan="1">25.0 (4.8)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">42 (4.9)</td>
<td align="left" colspan="1" rowspan="1">404 (47.1)</td>
<td align="left" colspan="1" rowspan="1">11 (1.3)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Seeger et al. 2019 [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]</td>
<td align="left" colspan="1" rowspan="1">OAC</td>
<td align="left" colspan="1" rowspan="1">136</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SAPT</td>
<td align="left" colspan="1" rowspan="1">118</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Suri et al. 2013 [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]</td>
<td align="left" colspan="1" rowspan="1">VKA</td>
<td align="left" colspan="1" rowspan="1">5,963</td>
<td align="left" colspan="1" rowspan="1">59.67 (13.35)</td>
<td align="left" colspan="1" rowspan="1">3,578 (60.0)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">513 (8.6)</td>
<td align="left" colspan="1" rowspan="1">3,305 (55.4)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">59.33 (8.9)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SAPT</td>
<td align="left" colspan="1" rowspan="1">7,119</td>
<td align="left" colspan="1" rowspan="1">57.33 (12.6)</td>
<td align="left" colspan="1" rowspan="1">4,148 (58.3)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">635 (8.9)</td>
<td align="left" colspan="1" rowspan="1">3,933 (55.2)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">59 (8.16)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="3" colspan="1"> Waechter et al. 2022 [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]</td>
<td align="left" colspan="1" rowspan="1">No APT</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">72.5 (11)</td>
<td align="left" colspan="1" rowspan="1">8 (72.7)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">9 (81.8)</td>
<td align="left" colspan="1" rowspan="1">3 (27.3)</td>
<td align="left" colspan="1" rowspan="1">4 (36.4)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
<td align="left" colspan="1" rowspan="1">11 (100)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OAC</td>
<td align="left" colspan="1" rowspan="1">146</td>
<td align="left" colspan="1" rowspan="1">78.9 (7.5)</td>
<td align="left" colspan="1" rowspan="1">86 (58.9)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">135 (92.5)</td>
<td align="left" colspan="1" rowspan="1">46 (31.5)</td>
<td align="left" colspan="1" rowspan="1">119 (81.5)</td>
<td align="left" colspan="1" rowspan="1">14 (9.6)</td>
<td align="left" colspan="1" rowspan="1">85 (58.2)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OAC + SAPT</td>
<td align="left" colspan="1" rowspan="1">248</td>
<td align="left" colspan="1" rowspan="1">78.4 (8)</td>
<td align="left" colspan="1" rowspan="1">157 (63.3)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">234 (94.4)</td>
<td align="left" colspan="1" rowspan="1">78 (31.5)</td>
<td align="left" colspan="1" rowspan="1">216 (87.1)</td>
<td align="left" colspan="1" rowspan="1">31 (12.5)</td>
<td align="left" colspan="1" rowspan="1">144 (58.1)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> van der Wall et al. 2018 [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]</td>
<td align="left" colspan="1" rowspan="1">VKA</td>
<td align="left" colspan="1" rowspan="1">325</td>
<td align="left" colspan="1" rowspan="1">60 (13)</td>
<td align="left" colspan="1" rowspan="1">195 (60)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">17 (5.4)</td>
<td align="left" colspan="1" rowspan="1">149 (47)</td>
<td align="left" colspan="1" rowspan="1">7 (2.2)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SAPT</td>
<td align="left" colspan="1" rowspan="1">144</td>
<td align="left" colspan="1" rowspan="1">62 (11)</td>
<td align="left" colspan="1" rowspan="1">85 (59)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">5 (3.5)</td>
<td align="left" colspan="1" rowspan="1">74 (51)</td>
<td align="left" colspan="1" rowspan="1">8 (5.6)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Noohi et al. 2020 [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]</td>
<td align="left" colspan="1" rowspan="1">OAC</td>
<td align="left" colspan="1" rowspan="1">153</td>
<td align="left" colspan="1" rowspan="1">49.9 ± 15</td>
<td align="left" colspan="1" rowspan="1">60 (39.5%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">24 (15.7%)</td>
<td align="left" colspan="1" rowspan="1">7 (4.9%)</td>
<td align="left" colspan="1" rowspan="1">35 (22.9%</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">44.01 ± 10.4</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VKA</td>
<td align="left" colspan="1" rowspan="1">144</td>
<td align="left" colspan="1" rowspan="1">51.9 ± 14.3</td>
<td align="left" colspan="1" rowspan="1">51 (35.4%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">25 (17.4%)</td>
<td align="left" colspan="1" rowspan="1">34 (22.2%)</td>
<td align="left" colspan="1" rowspan="1">58 (40.3%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">46.66 ± 9.2</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Valeur et al. 2016 [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]</td>
<td align="left" colspan="1" rowspan="1">SAPT</td>
<td align="left" colspan="1" rowspan="1">1437</td>
<td align="left" colspan="1" rowspan="1">Median, 64</td>
<td align="left" colspan="1" rowspan="1">960 (67%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">158 (11%)</td>
<td align="left" colspan="1" rowspan="1">175 (12%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">73 (5%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VKA</td>
<td align="left" colspan="1" rowspan="1">751</td>
<td align="left" colspan="1" rowspan="1">Median, 63</td>
<td align="left" colspan="1" rowspan="1">559 (74%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">86 (10%)</td>
<td align="left" colspan="1" rowspan="1">59 (8%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">19 (3%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1"> Watt et al. 2020 [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]</td>
<td align="left" colspan="1" rowspan="1">VKA</td>
<td align="left" colspan="1" rowspan="1">775</td>
<td align="left" colspan="1" rowspan="1">57 ± 13</td>
<td align="left" colspan="1" rowspan="1">442(57.0%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">74(9.6%)</td>
<td align="left" colspan="1" rowspan="1">347(44.8%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">57 ± 12%</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SAPT</td>
<td align="left" colspan="1" rowspan="1">322</td>
<td align="left" colspan="1" rowspan="1">55 ± 15</td>
<td align="left" colspan="1" rowspan="1">168(52.2%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">38(11.8%)</td>
<td align="left" colspan="1" rowspan="1">153(47.5%)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">57 ± 15%</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr><td align="left" colspan="14" rowspan="1">
<em>BMI</em>, Body mass index, <em>AF</em>, Atrial Fibrillation, <em>HTN</em>, Hypertension, <em>DM</em>, Diabetes mellitus, <em>MR</em>, mitral regurgitation, <em>LVEF</em>, Left ventricular ejection fraction, <em>DAPT</em>, Dual antiplatelet therapy, <em>SAPT</em>, Single antiplatelet therapy, <em>OAC</em>, oral anticoagulant, <em>VKA</em>, Vitamin K antagonist, <em>APT</em>, antiplatelet therapy</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec13"><h3 class="pmc_sec_title">Risk of bias assessment</h3>
<p id="Par52">According to the Newcastle–Ottawa scale, all included studies where good to high quality except Suri et al. 2013 [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>], Valeur et al. 2016 [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>], and Seeger et al. 2019 [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>] were poor quality and Körber et al. 2018 [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>] was fair quality. Detailed information about quality assessment is reported in Table <a href="#Tab3" class="usa-link">3</a>.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Riskof Bias Assessment: summarizing the quality assessment results of each study using the Newcastle-Ottawa scale, categorizing them by risk level</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Study ID</th>
<th align="left" colspan="1" rowspan="1">Hohmann et al. [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]</th>
<th align="left" colspan="1" rowspan="1">Wall et al. [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]</th>
<th align="left" colspan="1" rowspan="1">Benito-González et al. [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]</th>
<th align="left" colspan="1" rowspan="1">Suri et al. [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]</th>
<th align="left" colspan="1" rowspan="1">Paparella et al. [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]</th>
<th align="left" colspan="1" rowspan="1">Körber et al. [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]</th>
<th align="left" colspan="1" rowspan="1">Waechter et al. [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]</th>
<th align="left" colspan="1" rowspan="1">Noohi et al. [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]</th>
<th align="left" colspan="1" rowspan="1">Valeur et al. [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]</th>
<th align="left" colspan="1" rowspan="1">Watt et al. [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]</th>
<th align="left" colspan="1" rowspan="1">Seeger et al. [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]</th>
<th align="left" colspan="1" rowspan="1">Meurin et al. [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Sample selection criteria (****)</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
<td align="left" colspan="1" rowspan="1">****</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1) Representativeness of the exposed cohort (a) Truly representative (one star) (b) Somewhat representative (one star) (c) Selected group (d) No description of the derivation of the cohort</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2) Selection of the non-exposed cohort (a) Drawn from the same community as the exposed cohort (one star) (b) Drawn from a different source (c) No description of the derivation of the non-exposed cohort</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3) Ascertainment of exposure (a) Secure record (e.g., surgical record) (one star) (b) Structured interview (one star) (c) Written self-report (d) No description (e) Other</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4) Demonstration that outcome of interest was not present at start of study (a) Yes (one star) (b) No</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Comparability (**)</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1) Comparability of cohorts on the basis of the design or analysis controlled for confounders (a) The study controls for age, sex and marital status (one star) (b) Study controls for other factors (list) (one star) (c) Cohorts are not comparable on the basis of the design or analysis controlled for confounders</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1">**</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">**</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exposure (***)</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
<td align="left" colspan="1" rowspan="1">***</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1) Assessment of outcome (a) Independent blind assessment (one star) (b) Record linkage (one star) (c) Self report (d) No description (e) Other</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2) Was follow-up long enough for outcomes to occur (a) Yes (one star) (b) No</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3) Adequacy of follow-up of cohorts (a) Complete follow up- all subject accounted for (one star) (b) Subjects lost to follow up unlikely to introduce bias- number lost less than or equal to 20% or description of those lost suggested no different from those followed. (one star) (c) Follow up rate less than 80% and no description of those lost (d) No statement</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">*</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Summary quality score</td>
<td align="left" colspan="1" rowspan="1">Good</td>
<td align="left" colspan="1" rowspan="1">Good</td>
<td align="left" colspan="1" rowspan="1">Good</td>
<td align="left" colspan="1" rowspan="1">Poor</td>
<td align="left" colspan="1" rowspan="1">Good</td>
<td align="left" colspan="1" rowspan="1">Fair</td>
<td align="left" colspan="1" rowspan="1">Good</td>
<td align="left" colspan="1" rowspan="1">Good</td>
<td align="left" colspan="1" rowspan="1">Poor</td>
<td align="left" colspan="1" rowspan="1">Good</td>
<td align="left" colspan="1" rowspan="1">Poor</td>
<td align="left" colspan="1" rowspan="1">Good</td>
</tr>
<tr><td align="left" colspan="13" rowspan="1">
<p>ID, identification Score:</p>
<p>Good quality: 3 or 4 stars in selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome/exposure domain</p>
<p>Fair quality: 2 stars in selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome/exposure domain</p>
<p>Poor quality: 0 or 1 star in selection domain OR 0 stars in comparability domain OR 0 or 1 stars in outcome/exposure domain</p>
</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec14"><h3 class="pmc_sec_title">Outcomes</h3>
<section id="Sec15"><h4 class="pmc_sec_title">Bleeding events</h4>
<p id="Par53">Our network meta-analysis showed that the most effective intervention in decreasing the risk of bleeding after mitral valve repair (both surgical and transcatheter) was OAC in comparison to SAPT (RR = 0.31; 95% CI: [0.11–0.87]). The pooled studies showed moderate heterogeneity (I<sup>2</sup> = 57.5%, <em>P</em> = 0.038). The other interventions showed insignificant results in comparison to SAPT (VKA: RR = 0.79; 95% CI: [0.48; 1.30]), DAPT: (RR = 1.24; 95% CI: [0.51; 3.01]) (Figs. <a href="#Fig2" class="usa-link">2</a> and <a href="#Fig3" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h5 class="obj_head">Fig. 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/ff8517a379db/12872_2025_4974_Fig2_HTML.jpg" loading="lazy" id="MO2" height="253" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Network Meta-Analysis of Bleeding Events: illustrating the risk ratio comparisons of bleeding events across different antithrombotic treatments after mitral valve repair. A lower risk of bleeding is associated with OAC relative to SAPT</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/459af649c346/12872_2025_4974_Fig3_HTML.jpg" loading="lazy" id="MO3" height="656" width="744" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Network Meta-Analysis of Bleeding Events: illustrating the risk ratio comparisons of bleeding events across different antithrombotic treatments after mitral valve repair. A lower risk of bleeding is associated with OAC relative to SAPT</p></figcaption></figure><p id="Par56">Also, OAC showed a lower risk of bleeding in comparison to DAPT (RR = 0.25, 95% CI: [0.08; 0.80] (Fig. <a href="#Fig4" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="Fig4"><h5 class="obj_head">Fig. 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/b73f303b3c20/12872_2025_4974_Fig4_HTML.jpg" loading="lazy" id="MO4" height="616" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Comparison of Bleeding Risk Between OAC and DAPT: displaying the relative risk of bleeding in patients treated with OAC compared to DAPT, showing a statistically significant reduction in bleeding risk with OAC</p></figcaption></figure><p id="Par58">In terms of publication bias, our analysis showed insignificant publication bias (<em>P</em>-value of Egger test = 0.81) (Fig. <a href="#Fig5" class="usa-link">5</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h5 class="obj_head">Fig. 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/2a6cd9be322e/12872_2025_4974_Fig5_HTML.jpg" loading="lazy" id="MO5" height="614" width="744" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Egger’s Test for Publication Bias: presenting the results of Egger’s test, evaluating potential publication bias across studies included in the meta-analysis of bleeding events</p></figcaption></figure></section><section id="Sec16"><h4 class="pmc_sec_title">Thromboembolic events</h4>
<p id="Par60">The network meta-analysis showed insignificant results in comparison to (SAPT [OAC + SAPT: RR = 0.14, 95% CI: [0.01; 2.79]), (OAC: RR = 0.23, 95% CI 0.01; 4.74), VKA: RR = 0.66, 95% CI 0.23; 1.38), (No APT: RR = 3.11, 95% CI 0.84; 11.75)] (Figs. <a href="#Fig6" class="usa-link">6</a> and <a href="#Fig7" class="usa-link">7</a>).</p>
<figure class="fig xbox font-sm" id="Fig6"><h5 class="obj_head">Fig. 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/31e7d42ac70c/12872_2025_4974_Fig6_HTML.jpg" loading="lazy" id="MO6" height="265" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Thromboembolic Events Across Interventions: compareing thromboembolic event rates among various antithrombotic therapies, showing no significant differences in risk</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig7"><h5 class="obj_head">Fig. 7.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/02cc98b598bc/12872_2025_4974_Fig7_HTML.jpg" loading="lazy" id="MO7" height="591" width="744" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Thromboembolic Events Across Interventions: compareing thromboembolic event rates among various antithrombotic therapies, showing no significant differences in risk</p></figcaption></figure><p id="Par63">The head-to-head comparison of these interventions showed insignificant results. The analysis showed no significant heterogeneity (I<sup>2</sup> = 50.6%, <em>p</em> = 0.1546) (Fig. <a href="#Fig8" class="usa-link">8</a>).</p>
<figure class="fig xbox font-sm" id="Fig8"><h5 class="obj_head">Fig. 8 .</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/23358e1f4ffa/12872_2025_4974_Fig8_HTML.jpg" loading="lazy" id="d33e2377" height="1015" width="741" alt="Fig. 8 "></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Network meta-analysis comparing the relative risk (RR) of different antithrombotic and anticoagulant strategies. </p></figcaption></figure></section><section id="Sec17"><h4 class="pmc_sec_title">Transient ischemic attacks</h4>
<p id="Par65">The meta-analysis showed insignificant results between SAPT and VKA (RR = 0.48, 95% CI 0.12; 1.84, <em>P</em> = 0.28). The pooled studies were homogenous (I<sup>2</sup> = 0%, <em>p</em> = 0.83) (Fig. <a href="#Fig9" class="usa-link">9</a>).</p>
<figure class="fig xbox font-sm" id="Fig9"><h5 class="obj_head">Fig. 9.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/7882fcd6ce17/12872_2025_4974_Fig9_HTML.jpg" loading="lazy" id="MO9" height="175" width="669" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Risk of Transient Ischemic Attacks (TIA): showing the comparative risk of TIA between SAPT and VKA, with no significant difference observed</p></figcaption></figure></section><section id="Sec18"><h4 class="pmc_sec_title">Stroke</h4>
<p id="Par67">The pooled studies showed insignificant results between SAPT and VKA (RR = 1.11, 95% CI 0.85; 1.44, <em>P</em> = 0.43). The pooled studies showed insignificant heterogeneity (I<sup>2</sup> = 24%, <em>p</em> = 0.26) (Fig. <a href="#Fig10" class="usa-link">10</a>).</p>
<figure class="fig xbox font-sm" id="Fig10"><h5 class="obj_head">Fig. 10.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig10_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/50d5d89fbabc/12872_2025_4974_Fig10_HTML.jpg" loading="lazy" id="MO10" height="206" width="669" alt="Fig. 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Stroke Risk Comparison: providing a visual comparison of stroke risk between SAPT and VKA post-mitral valve repair</p></figcaption></figure></section><section id="Sec19"><h4 class="pmc_sec_title">6-month mortality</h4>
<p id="Par69">The pooled studies showed insignificant results between SAPT and VKA (RR = 1.20, 95% CI 0.18; 7.95, <em>P</em> = 0.85). The pooled studies were heterogeneous (I<sup>2</sup> = 80%, <em>p</em> &lt; 0.01) (Fig. <a href="#Fig11" class="usa-link">11</a>). The leave-one-out test was done. The heterogeneity resolved after removing Paparella et al. 2016 [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>] and the SAPT showed higher risk of 6-month mortality than VKA (RR = 2.95, 95% CI 1.28; 6.79, I<sup>2</sup> = 36%) (Fig. <a href="#Fig12" class="usa-link">12</a>).</p>
<figure class="fig xbox font-sm" id="Fig11"><h5 class="obj_head">Fig. 11.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig11_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/616e13ff46fc/12872_2025_4974_Fig11_HTML.jpg" loading="lazy" id="MO11" height="172" width="669" alt="Fig. 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Six-Month Mortality Risk Analysis: comparing six-month mortality risk across different treatments, with a significant finding upon exclusion of one study to reduce heterogeneity</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig12"><h5 class="obj_head">Fig. 12.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374401_12872_2025_4974_Fig12_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adbd/12374401/a186ab24b126/12872_2025_4974_Fig12_HTML.jpg" loading="lazy" id="MO12" height="142" width="669" alt="Fig. 12"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig12/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Six-Month Mortality Risk Analysis: comparing six-month mortality risk across different treatments, with a significant finding upon exclusion of one study to reduce heterogeneity</p></figcaption></figure></section><section id="Sec20"><h4 class="pmc_sec_title">Qualitative synthesis for transcatheter MVR</h4>
<p id="Par71">Benito-González et al. 2018 [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>] conducted a prospective cohort study on 80 patients who underwent percutaneous MVR with advanced functional class NYHA III-IV, 17.44 months as median follow-up time, and 96.3% procedural success rate. The bleeding events for our included interventions that reported in this study were as follows: DAPT 3/21, VKA 7/21, SAPT 2/21, OAC 3/21. Patients with AF were at high risk of thromboembolic events with HAS-BLED score (mean ± SD: 2.4 ± 1.2) and 40.4% were at high risk of bleeding events. Hohmann et al. 2022 [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>] reported MACE, all-cause mortality, combined bleeding endpoint that included intracranial, extra cranial, and gastrointestinal bleeding for 1342 patients with Mean Charlson Comorbidity Index 5.1 for patients who underwent percutaneous MVR using MitraClip. Events of MACE in DAPT, OAC, and No APT were less than 5, 8 and less than 5; respectively. Events of all-cause mortality in DAPT, OAC, and No APT were 31, 37, and 57; respectively. The gastrointestinal bleeding in DAPT, OAC, and No APT was 12, 6, and less than 5; respectively. Körber et al. 2018 [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>] reported that percutaneous MVR achieved 94.3% procedural success from total patients 327. They reported bleeding complications according to the definitions published by Mitral Valve Academic Research Consortium (MVARC). Bleeding events in VKA group were 31 from 104 patients, in OAC group were 5 from 49 patients, in SAPT group were 36 from 114 patients and in DAPT group 14 from 33 patients. Seeger et al. 2019 [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>] reported no bleeding events in either Apixaban plus aspirin or APT. However, Waechter et al. 2022 [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>] reported 16 (2.6%) Bleeding events and 3 (0.5%) thromboembolic events from 609 total cohort who underwent percutaneous MVR.</p></section></section></section><section id="Sec21"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par72">This systematic review aimed to compare different AT medications after MVR. Including nine studies in this network analysis, we found that all analyzed AT medications were comparable regarding TE events. However, VKA and OAC + SAPT were linked to a reduced incidence of TE events compared to those who received no AT medications. Our network meta-analysis showed that only OAC was associated with a lower risk of bleeding; it showed significant results compared to SAPT and DAPT. Also, there was no significant difference between SAPT and VKA in the risk of TIA, stroke, or six-month mortality.</p>
<section id="Sec22"><h3 class="pmc_sec_title">Thromboembolic events</h3>
<p id="Par73">Our findings on TE events following MVR suggest that AT medications (VKA and OAC + SAPT) are linked to a reduced incidence of TE events compared to those who did not receive AT medications. However, our study did not find any significant differences between different types of AT medications. These results are consistent with the findings of multiple previous studies.</p>
<p id="Par74">A multicenter cohort study conducted by Waechter et al. [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>] on 609 patients undergoing TMVR using transcatheter edge-to-edge repair (TEER) in Germany found that TE events were similar in patients treated with SAPT, DAPT OAC, OAC + SAPT, and OAC + DAPT (<em>p</em> = 1). Other studies conducted in France and the Netherlands have also shown that different AT medications do not differ significantly regarding the incidence of TE. A study conducted by Meurin et al. [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>] on 350 patients treated with VKA, ASA, or ASA + VKA after SMVR found that only the absence of AT therapy was associated with an increased risk of TE events in the first six weeks after surgery (hazard ratio (HR) = 6.7, 95% CI: [2.1–21], <em>p</em> = 0.0002), while all AT medications were comparable. Similarly, a study by Wall et al. [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>] on 469 patients who received VKA or ASA after SMVR found no significant differences in TE rates (three months adjusted HR = 0.82, 95%CI: [0.16, 4.2]).</p>
<p id="Par75">Although there was no significant difference in TE complications between the different AT medications, the study found that the incidence of TE was less than half in the VKA and OAC + SAPT groups. This suggests that these two AT regimens may provide protection against TE. However, larger studies are necessary to fully evaluate this matter due to the low event rate.</p>
<p id="Par76">In a retrospective study conducted by Watt et al. [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>] on 1097 patients who underwent SMVR, it was found that there was no significant difference in TE between patients treated with VKA and those who did not receive AT treatment (<em>p</em> = 0.1). However, excluding patients with AF in Watt et al.‘s study [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>] may have led to controversial results. AT medications play a major role in such a population, and even with that exclusion, the TE events were half in the patients who received VKA compared to those who did not (1.5% vs. 3.1%).</p>
<p id="Par77">Also, our analysis resulted in insignificant results between VKA and SAPT regarding TIA and stroke, which align with that of Paparella et al. 2016 [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>], Wall et al. 2018 [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>], Watt et al. 2020 [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>], Valeur et al. 2016 [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>], and Suri et al. 2013 [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p></section><section id="Sec23"><h3 class="pmc_sec_title">Bleeding</h3>
<p id="Par78">Our network meta-analysis showed that the least risk of bleeding was associated with OAC; it showed significant results compared to SAPT and DAPT. Our findings align with that of Körber et al. 2018 [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. They retrospectively assessed a cohort of 353 patients who underwent PMVR in Germany between November 2012 and June 2016. The least risk of bleeding was associated with OAC (1.6%) ompared to VKA (10.2%), SAPT (11.7%), and DAPT (4.56%). Noohi et al. [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>] reported equal bleeding events after OAC (rivaroxaban) (1.9%) and VKA (4%) (<em>p</em> = 0.4) in their cohort of patients undergoing SMVR.</p>
<p id="Par79">Notably, several outcomes in our analysis demonstrated moderate to substantial heterogeneity, particularly in the assessment of bleeding and six-month mortality. This heterogeneity may be attributed to several factors, including variability in patient populations, especially between those undergoing surgical versus transcatheter mitral valve repair. Patients selected for transcatheter procedures often represent a higher surgical risk and may have different comorbidity profiles, which can influence both thrombotic and bleeding risks. Additionally, differences in antithrombotic protocols across studies, such as drug combinations, dosages, and timing of administration, contribute to inter-study variability. Variation in follow-up duration and methodological quality, including retrospective versus prospective design and outcome definitions, may also have played a role.</p>
<p id="Par80">To explore the source of heterogeneity in the six-month mortality analysis, we conducted a leave-one-out sensitivity analysis, which revealed that the study by Paparella et al. 2016 had a significant impact on both heterogeneity and pooled effect estimates. Upon exclusion of this study, heterogeneity dropped from I² = 80–36%, and a statistically significant increase in mortality risk associated with SAPT compared to VKA emerged (RR = 2.95, 95% CI: 1.28–6.79). This suggests that Paparella et al. may have introduced heterogeneity due to unique patient characteristics, treatment practices, or reporting methodologies. These findings emphasize the importance of sensitivity analyses in interpreting meta-analytic data and suggest that conclusions regarding mortality should be interpreted cautiously, especially when influenced by outlier studies.</p>
<p id="Par81">Watt et al. 2020 reported that VKA was associated with a significant decrease in the risk of bleeding than the SAPT (0.9% vs. 3.1%, <em>p</em> = 0.007). One possible explanation for this could be that patients who were deemed more susceptible to bleeding incidents after surgery were less likely to be prescribed anticoagulants based on the surgeon’s preference. Additionally, a significant proportion of patients in the non-anticoagulated group experienced pericardial tamponade bleeding (<em>p</em> = 0.045), which further supports the previous explanation when compared to the VKA group.</p>
<p id="Par82">Currently, a lack of recent data clarifies this issue with the use of OAC. However, we can assume that OACs have a lower risk of major bleeding than VKA based on the results of landmark studies that compared them to valvular heart disease patients with valvular heart diseases and prosthetic valves [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p>
<p id="Par83">Given the ongoing debate on postoperative anticoagulation and the variability in clinical practices, this study underscores the significance of further exploring this matter through RCTs. Our network meta-analysis has major limitations due to the heterogeneity between the studies that were pooled. There are several reasons for this. Firstly, there is a significant difference between the demographic profiles of PMVR and SMVR candidates. Currently, PMVR is recommended for patients with a higher surgical risk. As we had limited data from studies using PMVR, we were unable to address this issue through subgroup analysis. Secondly, the empirical AT treatment of MVR patients is highly variable in real-world settings because of the lack of evidence-based data available. It is directly associated with the institution and surgeon’s experience and choice. Thirdly, the included studies were retrospective in design, which makes them more susceptible to confounding factors such as surgeon experience. Finally, a third of the studies we included had a high risk of bias.</p>
<p id="Par84">AT regimens of OAC may be highly relevant for patients with AF. However, it remains unclear whether OAC will have the same properties when used for patients with less prevalent AF, such as SMVR candidates. We were not able to study this subgroup due to insufficient data.</p>
<p id="Par85">Our analysis demonstrated that AT medications had beneficial effects, but RCTs should be conducted to account for confounding factors in observational studies and determine which group of MVR candidates would benefit from AT medications. Although the limited number of studies under each treatment group and the high level of heterogeneity between patients mean that our results should be taken as hypothesis-formulating, AT medications did not increase the risk for adverse events and may be beneficial. Additionally, due to the limited number of high-quality studies available for each type of mitral valve repair individually, this approach allowed us to include a broader range of evidence and enhance the statistical power; however, we acknowledge the inherent differences between these procedural modalities as patient risk profiles and perioperative management.</p>
<p id="Par86">We recognize this as a potential limitation and have emphasized the need for future studies that separately analyze antithrombotic strategies in more homogenous populations undergoing either surgical or transcatheter repair. In addition, While we used the NOS to assess the quality of included observational studies due to its broad acceptance and simplicity, we acknowledge that prospective protocol registration and the ROBINS-I tool offer a more detailed risk-of-bias evaluation tailored to non-randomized intervention studies. Future systematic reviews might benefit from applying both tools, particularly when assessing the causal impact of interventions. Our choice of NOS was aimed at consistency with previous evidence in similar settings and for better comparability of findings.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par87">Our analysis indicates that OACs are associated with a lower risk of bleeding compared to single or dual antiplatelet therapy after mitral valve repair, while VKAs and OAC + SAPT may offer better protection against thromboembolic events than no therapy. However, differences between antiplatelet and anticoagulant strategies were not significant for stroke, TIA, or short-term mortality in most comparisons. These findings highlight the need for individualized decision-making, particularly in patients with atrial fibrillation or elevated thromboembolic risk. Current evidence remains limited and inconsistent, underscoring the need for RCTs to guide antithrombotic therapy following mitral valve repair.</p></section></section><section id="Sec25"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12374401/bin/12872_2025_4974_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (270.5KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>None to declare.</p>
<section id="FPar1"><h3 class="pmc_sec_title">Clinical trial number</h3>
<p id="Par88">not applicable.</p></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>MR</dt>
<dd><p id="Par5">Mitral Regurgitation</p></dd>
<dt>MV</dt>
<dd><p id="Par6">Mitral Valve</p></dd>
<dt>SMVR</dt>
<dd><p id="Par7">Surgical Mitral Valve Repair</p></dd>
<dt>PMVR</dt>
<dd><p id="Par8">Percutaneous Mitral Valve Repair</p></dd>
<dt>TMVR</dt>
<dd><p id="Par9">Transcatheter Mitral Valve Repair</p></dd>
<dt>TE</dt>
<dd><p id="Par10">Thromboembolic</p></dd>
<dt>AT</dt>
<dd><p id="Par11">Antithrombotic</p></dd>
<dt>ESC</dt>
<dd><p id="Par12">European Society of Cardiology</p></dd>
<dt>EACTS</dt>
<dd><p id="Par13">European Association for Cardio-Thoracic Surgery</p></dd>
<dt>ACC</dt>
<dd><p id="Par14">American College of Cardiology</p></dd>
<dt>AHA</dt>
<dd><p id="Par15">American Heart Association</p></dd>
<dt>AF</dt>
<dd><p id="Par16">Atrial Fibrillation</p></dd>
<dt>RCT</dt>
<dd><p id="Par17">Randomized Controlled Trial</p></dd>
<dt>NOS</dt>
<dd><p id="Par18">Newcastle-Ottawa Scale</p></dd>
<dt>ASA</dt>
<dd><p id="Par19">Acetylsalicylic Acid (Aspirin)</p></dd>
<dt>VKA</dt>
<dd><p id="Par20">Vitamin K Antagonist</p></dd>
<dt>OAC</dt>
<dd><p id="Par21">Oral Anticoagulant</p></dd>
<dt>SAPT</dt>
<dd><p id="Par22">Single Antiplatelet Therapy</p></dd>
<dt>DAPT</dt>
<dd><p id="Par23">Dual Antiplatelet Therapy</p></dd>
<dt>No APT</dt>
<dd><p id="Par24">No Antiplatelet Therapy</p></dd>
<dt>TIA</dt>
<dd><p id="Par25">Transient Ischemic Attack</p></dd>
<dt>CI</dt>
<dd><p id="Par26">Confidence Interval</p></dd>
<dt>RR</dt>
<dd><p id="Par27">Risk Ratio</p></dd>
<dt>PRISMA</dt>
<dd><p id="Par28">Preferred Reporting Items for Systematic Reviews and Meta-Analyses</p></dd>
<dt>MVARC</dt>
<dd><p id="Par29">Mitral Valve Academic Research Consortium</p></dd>
<dt>MACE</dt>
<dd><p id="Par30">Major Adverse Cardiac Events</p></dd>
<dt>NYHA</dt>
<dd><p id="Par31">New York Heart Association</p></dd>
<dt>SD</dt>
<dd><p id="Par32">Standard Deviation</p></dd>
<dt>HR</dt>
<dd><p id="Par33">Hazard Ratio</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>(Gbreel MI, Elkasaby MH &amp; Balata MB) Conceptualization, Methodology, Software, Formal analysis, Project Administration. (Gbreel MI &amp; Hassan H) Conceptualization, Writing –, Writing – review &amp; editing, Visualization. (Gbreel MI, Elkasaby MH &amp; Becher MU) Writing – review &amp; editing. (Balata M &amp; Becher MU) Conceptualization, Methodology, Writing – original draft preparation, Writing – review &amp; editing, Supervision.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open Access funding enabled and organized by Projekt DEAL. No commercial funding received for this work.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar2"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par89">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par90">Not applicable.</p></section><section id="FPar5"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par91">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ol class="ref-list font-sm">
<li id="CR1">
<cite>Watt TMF, Murray SL, Brescia AA, Burn DA, Wisniewski A, Khan SP, et al. Anticoagulation following mitral valve repair. J Card Surg. 2020;35:2887–94.</cite> [<a href="https://doi.org/10.1111/jocs.14902" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7722210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32741031/" class="usa-link">PubMed</a>]</li>
<li id="CR2">
<cite>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.</cite> [<a href="https://doi.org/10.1136/bmj.315.7109.629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2127453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9310563/" class="usa-link">PubMed</a>]</li>
<li id="CR3"><cite>Posit Software P. RStudio Desktop - Posit. 2023.</cite></li>
<li id="CR4"><cite>R-Foundation. The R Project for Statistical Computing. 2003.</cite></li>
<li id="CR5"><cite>Wells G, Shea B, O’Connell D, Peterson J. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: Ottawa, ON: Ottawa Hospital Research Institute. 2000.</cite></li>
<li id="CR6">
<cite>Bramer WM, Milic J, Mast F. Reviewing retrieved references for inclusion in systematic reviews using EndNote. Journal of the Medical Library Association. 2017;105.</cite> [<a href="https://doi.org/10.5195/jmla.2017.111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5234463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28096751/" class="usa-link">PubMed</a>]</li>
<li id="CR7">
<cite>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71.</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>]</li>
<li id="CR8">
<cite>van der Wall SJ, Olsthoorn JR, Heuts S, Klautz RJM, Tomsic A, Jansen EK, et al. Antithrombotic therapy after mitral valve repair: VKA or aspirin? J Thromb Thrombolysis. 2018;46:473–81.</cite> [<a href="https://doi.org/10.1007/s11239-018-1724-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6182386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30132244/" class="usa-link">PubMed</a>]</li>
<li id="CR9">
<cite>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Wiley; 2019.</cite> [<a href="https://doi.org/10.1002/14651858.ED000142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10284251/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31643080/" class="usa-link">PubMed</a>]</li>
<li id="CR10">
<cite>Russo A, Grigioni F, Avierinos J-F, Freeman WK, Suri R, Michelena H, et al. Thromboembolic Complications After Surgical Correction of Mitral Regurgitation. J Am Coll Cardiol. 2008;51:1203–11.</cite> [<a href="https://doi.org/10.1016/j.jacc.2007.10.058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18355659/" class="usa-link">PubMed</a>]</li>
<li id="CR11">
<cite>Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77:e25–197.</cite> [<a href="https://doi.org/10.1016/j.jacc.2020.11.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33342586/" class="usa-link">PubMed</a>]</li>
<li id="CR12">
<cite>Vahanian A, Beyersdorf F. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Journal of Cardio-thoracic Surgery. 2021;60:727–800.</cite> [<a href="https://doi.org/10.1093/ejcts/ezab389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34453161/" class="usa-link">PubMed</a>]</li>
<li id="CR13">
<cite>Del Forno B, De Bonis M, Agricola E, Melillo F, Schiavi D, Castiglioni A, et al. Mitral valve regurgitation: a disease with a wide spectrum of therapeutic options. Nat Rev Cardiol. 2020;17:807–27.</cite> [<a href="https://doi.org/10.1038/s41569-020-0395-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32601465/" class="usa-link">PubMed</a>]</li>
<li id="CR14">
<cite>Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou J-B, Anisubia B, et al. The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 2016;109:321–9.</cite> [<a href="https://doi.org/10.1016/j.acvd.2015.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26988837/" class="usa-link">PubMed</a>]</li>
<li id="CR15">
<cite>Dziadzko V, Dziadzko M, Medina-Inojosa JR, Benfari G, Michelena HI, Crestanello JA, et al. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J. 2019;40:2194–202.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31121021/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<cite>Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, et al. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017. Circulation. 2020;141:1670–80.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.119.043391" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32223336/" class="usa-link">PubMed</a>]</li>
<li id="CR17">
<cite>Suri RM, Thourani VH, He X, Brennan JM, O’Brien SM, Rankin JS, et al. Variation in Warfarin Thromboprophylaxis After Mitral Valve Repair: Does Equipoise Exist and Is a Randomized Trial Warranted? Ann Thorac Surg. 2013;95:1991–9.</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2013.03.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23706423/" class="usa-link">PubMed</a>]</li>
<li id="CR18">
<cite>Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Medical Sciences. 2022;10:32.</cite> [<a href="https://doi.org/10.3390/medsci10020032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9228968/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35736352/" class="usa-link">PubMed</a>]</li>
<li id="CR19">
<cite>Waechter C, Ausbuettel F, Chatzis G, Cheko J, Fischer D, Nef H, et al. Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients. J Cardiovasc Dev Dis. 2022;9.</cite> [<a href="https://doi.org/10.3390/jcdd9110366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9695441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36354765/" class="usa-link">PubMed</a>]</li>
<li id="CR20">
<cite>Suri RM, Thourani VH, He X, Brennan JM, O’Brien SM, Rankin JS, et al. Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted? Ann Thorac Surg. 2013;95:1991–8; discussion 1998-9.</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2013.03.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23706423/" class="usa-link">PubMed</a>]</li>
<li id="CR21">
<cite>Renda G, Ricci F, Giugliano RP, De Caterina R. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease. J Am Coll Cardiol. 2017;69:1363–71.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.12.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28302287/" class="usa-link">PubMed</a>]</li>
<li id="CR22">
<cite>Noohi F, Sadeghipour P, Kordrostami S, Shafe O, Maleki M, Kyavar M, et al. Rivaroxaban in patients undergoing surgical mitral valve repair. J Thromb Thrombolysis. 2020;49:475–9.</cite> [<a href="https://doi.org/10.1007/s11239-020-02046-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32002769/" class="usa-link">PubMed</a>]</li>
<li id="CR23">
<cite>Körber MI, Silwedel J, Friedrichs K, Mauri V, Huntgeburth M, Pfister R, et al. Bleeding Complications After Percutaneous Mitral Valve Repair With the MitraClip. American Journal of Cardiology. 2018;121:94–9.</cite> [<a href="https://doi.org/10.1016/j.amjcard.2017.09.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29122275/" class="usa-link">PubMed</a>]</li>
<li id="CR24">
<cite>Valeur N, Mérie C, Hansen ML, Torp-Pedersen C, Gislason GH, Kober L, et al. Risk of death and stroke associated with anticoagulation therapy after mitral valve repair. 10.1136/heartjnl.</cite> [<a href="https://doi.org/10.1136/heartjnl-2015-308272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26729693/" class="usa-link">PubMed</a>]</li>
<li id="CR25">
<cite>Paparella D, Di Mauro M, Bitton Worms K, Bolotin G, Russo C, Trunfio S, et al. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair. Journal of Thoracic and Cardiovascular Surgery. 2016;151:1302–1308.e1.</cite> [<a href="https://doi.org/10.1016/j.jtcvs.2015.12.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26832208/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<cite>Watt TMF, Murray SL, Brescia AA, Burn DA, Wisniewski A, Khan SP, et al. Anticoagulation following mitral valve repair. J Card Surg. 2020;35:2887–94.</cite> [<a href="https://doi.org/10.1111/jocs.14902" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7722210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32741031/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<cite>van der Wall SJ, Olsthoorn JR, Heuts S, Klautz RJM, Tomsic A, Jansen EK, et al. Antithrombotic therapy after mitral valve repair: VKA or aspirin? J Thromb Thrombolysis. 2018;46:473–81.</cite> [<a href="https://doi.org/10.1007/s11239-018-1724-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6182386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30132244/" class="usa-link">PubMed</a>]</li>
<li id="CR28">
<cite>Valeur N, Mérie C, Hansen ML, Torp-Pedersen C, Gislason GH, Kober L. Risk of death and stroke associated with anticoagulation therapy after mitral valve repair. Heart. 2016;102:687–93.</cite> [<a href="https://doi.org/10.1136/heartjnl-2015-308272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26729693/" class="usa-link">PubMed</a>]</li>
<li id="CR29">
<cite>Meurin P, Tabet JY, Iliou MC, Pierre B, Corone S, Cristofini P, et al. Thromboembolic events early after mitral valve repair: Incidence and predictive factors. Int J Cardiol. 2008;126:45–52.</cite> [<a href="https://doi.org/10.1016/j.ijcard.2007.03.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17490763/" class="usa-link">PubMed</a>]</li>
<li id="CR30">
<cite>Benito-González T, Estévez-Loureiro R, de Prado AP, Minguito-Carazo C, Del Castillo García S, Garrote-Coloma C, et al. Incidence and prognostic implications of late bleeding events after percutaneous mitral valve repair. Int J Cardiol Heart Vasc. 2018;21:16–21.</cite> [<a href="https://doi.org/10.1016/j.ijcha.2018.09.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6148729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30255126/" class="usa-link">PubMed</a>]</li>
<li id="CR31">
<cite>Hohmann C, Ludwig M, Walker J, Iliadis C, Schipper J-H, Baldus S, et al. Real-world anticoagulatory treatment after percutaneous mitral valve repair using MitraClip: a retrospective, observational study on 1300 patients. Clin Res Cardiol. 2022;111:889–99.</cite> [<a href="https://doi.org/10.1007/s00392-022-01988-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9334399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35220447/" class="usa-link">PubMed</a>]</li>
<li id="CR32">
<cite>Körber MI, Silwedel J, Friedrichs K, Mauri V, Huntgeburth M, Pfister R, et al. Bleeding Complications After Percutaneous Mitral Valve Repair With the MitraClip. Am J Cardiol. 2018;121:94–9.</cite> [<a href="https://doi.org/10.1016/j.amjcard.2017.09.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29122275/" class="usa-link">PubMed</a>]</li>
<li id="CR33">
<cite>Meurin P, Tabet JY, Iliou MC, Pierre B, Corone S, Cristofini P, et al. Thromboembolic events early after mitral valve repair: incidence and predictive factors. Int J Cardiol. 2008;126:45–52.</cite> [<a href="https://doi.org/10.1016/j.ijcard.2007.03.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17490763/" class="usa-link">PubMed</a>]</li>
<li id="CR34">
<cite>Noohi F, Sadeghipour P, Kordrostami S, Shafe O, Maleki M, Kyavar M, et al. Rivaroxaban in patients undergoing surgical mitral valve repair. J Thromb Thrombolysis. 2020;49:475–9.</cite> [<a href="https://doi.org/10.1007/s11239-020-02046-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32002769/" class="usa-link">PubMed</a>]</li>
<li id="CR35">
<cite>Paparella D, Di Mauro M, Bitton Worms K, Bolotin G, Russo C, Trunfio S, et al. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair. J Thorac Cardiovasc Surg. 2016;151:1302-8.e1.</cite> [<a href="https://doi.org/10.1016/j.jtcvs.2015.12.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26832208/" class="usa-link">PubMed</a>]</li>
<li id="CR36">
<cite>Seeger J, Markovic S, Kessler M, Rottbauer W, Wöhrle J. Apixaban After Percutaneous Edge-to-Edge Mitral Valve Repair in Patients With Maintained Sinus Rhythm. JACC Cardiovasc Interv. 2019;12:214–6.</cite> [<a href="https://doi.org/10.1016/j.jcin.2018.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30678801/" class="usa-link">PubMed</a>]</li>
<li id="CR37">
<cite>Waechter C, Ausbuettel F, Chatzis G, Cheko J, Fischer D, Nef H, et al. Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients. J Cardiovasc Dev Dis. 2022;9.</cite> [<a href="https://doi.org/10.3390/jcdd9110366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9695441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36354765/" class="usa-link">PubMed</a>]</li>
<li id="CR38">
<cite>Guimarães PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, et al. Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial. Clin Cardiol. 2019;42:568–71.</cite> [<a href="https://doi.org/10.1002/clc.23178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6522998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30907005/" class="usa-link">PubMed</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374401/bin/12872_2025_4974_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (270.5KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Cardiovascular Disorders are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12872-025-04974-4"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12872_2025_Article_4974.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374401/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374401/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374401%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374401/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374401/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374401/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40849614/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374401/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40849614/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374401/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374401/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Vdnx3zqPcc5SZ7QU75NNyKogzkmpSief0qfzuTBgsemDdfWuret4fckE40OpjwJ7">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
